Biologic and clinical implications of marrow culture studies in the myelodysplastic syndromes
Greenberg, P.L.
Seminars in Hematology 33(2): 163-175
1996
ISSN/ISBN: 0037-1963 PMID: 8722686 Document Number: 460162
Document emailed within 1 workday
Related Documents
Li, L.-j.; Fu, R.; Wang, H.-q.; Yue, L.-z.; Liu, H.; Wang, J.; Wang, H.-l.; Ruan, E.-b.; Qu, W.; Liang, Y.; Wang, G.-j.; Wang, X.-m.; Liu, H.; Song, J.; Wu, Y.-h.; Xing, L.-m.; Guan, J.; Shao, Z.-h. 2010: Expression of differentiation antigens on bone marrow myeloid cells of the patients with myelodysplastic syndromes and its clinical significances Zhonghua Yi Xue Za Zhi 90(10): 672-677Montecucco, C.; Riccardi, A.; Ascari, E. 1987: Bone marrow cell kinetics in primary myelodysplastic syndromes Haematologica 72(6 Suppl): 132-134
Werner, M.; Maschek, H.J.; Kaloutsi, V.; Buhr, T.; Kausche, F.; Delventhal, S.; Georgii, A. 1990: Cytogenetic examination of bone marrow cells in stem cell diseases of myelodysplastic syndromes Verhandlungen der Deutschen Gesellschaft für Pathologie 74: 139-143
Kitagawa, M.; Saito, I.; Kuwata, T.; Yoshida, S.; Yamaguchi, S.; Takahashi, M.; Tanizawa, T.; Kamiyama, R.; Hirokawa, K. 1997: Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes Leukemia 11(12): 2049-2054
De Witte, T.; Zwaan, F.; Hermans, J.; Vernant, J.; Kolb, H.; Vossen, J.; Lönnqvist, B.; Beelen, D.; Ferrant, A.; Gmür, J. 1989: Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndromes. Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG) Bone Marrow Transplantation 4(Suppl 3): 38-39
Mariańska, B.; Apel, D.; Maj, S. 1991: Results of selected cytochemical studies of mature granulocytes in myelodysplastic syndromes and various other hematologic diseases Acta Haematologica Polonica 22(1): 54-57
Ganser, A.; Hoelzer, D. 1996: Clinical use of hematopoietic growth factors in the myelodysplastic syndromes Seminars in Hematology 33(3): 186-195
Bernasconi, C.; Lazzarino, M.; Morra, E.; Alessandrino, E.P.; Brusamolino, E.; Bernasconi, P.; Inverardi, D. 1989: Myelodysplastic syndromes: multiplicity of the hematologic and clinical aspects Haematologica 74(5): 110-127
Giralt, M.; Rubio-Félix, D.; Sala, F.; Perdiguer, L.; Raichs, A. 1985: Clinical semiology, development and therapy of myelodysplastic syndromes Sangre 30(4-C): 705-712
Bernasconi, C.; Lazzarino, M.; Morra, E.; Alessandrino, E.P.; Brusamolino, E.; Bernasconi, P.; Inverardi, D. 1989: Myelodysplastic syndromes: multiplicity of the hematologic and clinical aspects Haematologica 74(5 Suppl): 110-127
Pruneri, G.; Fracchiolla, N.; Cortelezzi, A.; Ponzoni, M.; Maisonneuve, P.; Lambertenghi-Deliliers, G. 2003: The prevalence and clinical relevance of p27 and cyclin E immunoreactivity in myelodysplastic syndromes Haematologica 88(1): 109-110
Kimura, H.; Terasawa, T.; Maruyama, W.; Kasai, S.; Tanaka, T.; Matsuda, S.; Akitsuki, T.; Yoshida, H.; Uchida, T.; Kariyone, S. 1978: Erythroid colony formation in vitro by human marrow cells--fundamental studies by a modified plasma clot culture system and its clinical application Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 41(5): 837-845
Omine, M.; Yamauchi, H. 1989: Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB) Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 52(4): 800-810
Cortes, J.E.; Kantarjian, H.; O'Brien, S.; Keating, M.; Pierce, S.; Freireich, E.J.; Estey, E. 1995: Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes Leukemia 9(1): 115-117
Liu, H.; He, G.-s.; Wu, D.-p.; Sun, A.-n.; Shao, Z.-h.; Qian, S.-x.; Xiao, Z.-j.; Ma, J.; Wang, S.-y.; Xu, X.-p.; Liu, T.; Jin, J.; Chen, Z.-c.; Fang, M.-y.; Chen, B.-a.; Xu, L.-p.; Shen, Z.-x.; Ruan, C.-g. 2012: Clinical efficacies and safety of HAG regimen for patients with high-risk myelodysplastic syndromes: a multicentre study Zhonghua Yi Xue Za Zhi 92(10): 689-691
Minshew, N.J. 1991: Indices of neural function in autism: clinical and biologic implications Pediatrics 87(5 Part 2): 774-780
Rosen, T. 2012: Green tea catechins: biologic properties, proposed mechanisms of action, and clinical implications Journal of Drugs in Dermatology: Jdd 11(11): E55-E60
Tassin, F.; Hermanne, J.P.; Schaaf-Lafontaine, N.; Herens, C.; Thiry, A.; Paulus, J.M.; Boniver, J.; Fillet, G. 1998: Myelodysplastic syndromes: preleukemic syndromes Revue Medicale de Liege 53(6): 357-362
Jończyk, H.; Rudowski, W.; Traczyk, Z.; Klawe, Z.; Arczyńska, E. 1975: Studies on DDT and its metabolites as well as beta and gamma HCH in the blood, bone marrow and fatty tissue in some hematologic syndromes Polski Tygodnik Lekarski 30(46): 1909-1911
White, T.R.; Werner, G.F.; Flinn, R.S. 1970: Clinical implications of the trifascicular block syndromes Arizona Medicine 27(4): 69-71